Get the Stockscreener App
1.16
0.00%
0.00
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Zynex Inc stock is traded at $1.16, with a volume of 269.44K.
It is up +0.00% in the last 24 hours and up +1.75% over the past month.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.
See More
Previous Close:
$1.16
Open:
$1.16
24h Volume:
269.44K
Relative Volume:
0.06
Market Cap:
$32.38M
Revenue:
$144.81M
Net Income/Loss:
$-28.66M
P/E Ratio:
-1.2391
EPS:
-0.9362
Net Cash Flow:
$-7.67M
1W Performance:
-27.04%
1M Performance:
+1.75%
6M Performance:
-46.05%
1Y Performance:
-85.52%
1-Day Range:
$1.06
$1.17
1-Week Range:
$1.06
$1.68
52-Week Range:
$0.3759
$8.72
Zynex Inc Stock (ZYXI) Company Profile
Name
Zynex Inc
Sector
Industry
Phone
(800)-495-6670
Address
9655 MAROON CIRCLE, ENGLEWOOD, CO
Compare ZYXI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| 9.30 | 0 | 0 | 0 | 0 | 0.00 | |
MOBBW
Mobilicom Limited Warrants
|
3.2199 | 3.63B | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.2269 | 472.18M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
GOODO
Gladstone Commercial Corporation
|
20.21 | 372.90M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
4.655 | 204.55M | 0 | 0 | 0 | 0.00 |
|
DAVEW
Dave Inc
|
0.8738 | 0 | 0 | 0 | 0 | 0.00 |
Zynex Inc Stock (ZYXI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-01-25 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Aug-01-25 | Upgrade | Ladenburg Thalmann | Neutral → Buy |
| Mar-12-25 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Mar-12-25 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Oct-16-23 | Initiated | RBC Capital Mkts | Outperform |
| Jan-06-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Feb-28-22 | Reiterated | B. Riley Securities | Buy |
| Jul-16-21 | Upgrade | B. Riley Securities | Neutral → Buy |
| Mar-09-21 | Upgrade | Northland Capital | Market Perform → Outperform |
| Feb-26-21 | Downgrade | B. Riley Securities | Buy → Neutral |
| Jan-29-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jan-28-21 | Downgrade | Northland Capital | Outperform → Market Perform |
| Sep-14-20 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Sep-09-20 | Upgrade | Northland Capital | Market Perform → Outperform |
| Jul-29-20 | Upgrade | B. Riley FBR | Neutral → Buy |
| Jul-20-20 | Initiated | Piper Sandler | Overweight |
| Jul-13-20 | Downgrade | B. Riley FBR | Buy → Neutral |
| Jul-10-20 | Reiterated | H.C. Wainwright | Neutral |
| Jun-16-20 | Downgrade | Northland Capital | Outperform → Market Perform |
| May-19-20 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Apr-01-20 | Initiated | Northland Capital | Outperform |
| Sep-23-19 | Initiated | H.C. Wainwright | Buy |
View All
Zynex Inc Stock (ZYXI) Latest News
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Zynex, Inc. (ZYXI) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Zynex, Inc. (ZYXI) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Zynex, Inc. (ZYXI) And Encourages Investors to Reach Out - ACCESS Newswire
Zynex’s Q3 2025 Financial Struggles: Dramatic Revenue Decline and Liquidity Concerns - timothysykes.com
ZYXI LAWSUIT ALERT: Levi & Korsinsky Notifies Zynex, Inc. InvestorsLead Plaintiff Deadline May 19, 2025 - The National Law Review
Zynex, Inc. (ZYXI) stock forecast and price target - Yahoo Finance UK
Zynex Faces Financial Downturn as Revenue Plummets - timothysykes.com
Zynex Reports Second Quarter 2025 Financial Results (PR Newswire) - Aktiellt
Zynex, Inc. (ZYXI) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
Zynex, Inc. Sued for Securities Law ViolationsContact Levi & K - The National Law Review
ZYXI INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announc - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Zynex, Inc. (ZYXI) And Encourages Stockholders to Reach Out - ACCESS Newswire
3 Penny Stocks to Watch Now, 11/27/25 - TipRanks
Zynex Announces Arrival of Steven Dyson as CEO and Appointment of New Leadership in Key Roles (PR Newswire) - Aktiellt
Bronstein, Gewirtz & Grossman, LLC Is Investigating Zynex, Inc. (ZYXI) And Encourages Stockholders to Connect - ACCESS Newswire
Zynex (ZYXI) Price Target Decreased by 37.59% to 2.91 - MSN
Zynex, Inc. (ZYXI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Zynex Inc. Faces Legal and Regulatory Turmoil: Potential Impact on Financial Health and Operations - MSN
Zynex Inc. Earnings Call: Financial Challenges and Strategic Initiatives - MSN
Zynex Faces Financial Challenges Amid Revenue Decline - MSN
Zynex, Inc. (ZYXI) Investigation: Bronstein, Gewirtz & Grossman - The National Law Review
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Is Zynex Inc. stock a good choice for value investors2025 Winners & Losers & Daily Growth Stock Investment Tips - newser.com
What technical signals suggest for Zynex Inc. stockShare Buyback & Free Verified High Yield Trade Plans - newser.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Zynex, Inc. (ZYXI) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
How Zynex Inc. stock reacts to job market dataBreakout Watch & Comprehensive Market Scan Reports - newser.com
How to integrate Zynex Inc. into portfolio analysis toolsEarnings Overview Report & Weekly Breakout Watchlists - newser.com
Earnings Momentum Lifts PACS And Nutex; Zynex And Genenta Also Advance After Hours - Nasdaq
What candlestick patterns are forming on Zynex Inc.2025 Support & Resistance & Reliable Breakout Forecasts - newser.com
Can Zynex Inc. stock double in next 5 years2025 Earnings Surprises & Daily Technical Stock Forecast Reports - newser.com
Why Zynex Inc. stock could rally in 2025Weekly Market Report & Weekly High Conviction Trade Ideas - newser.com
Why Zynex Inc. stock could outperform in 2025Forecast Cut & Growth-Oriented Investment Plans - newser.com
Analyzing drawdowns of Zynex Inc. with statistical toolsM&A Rumor & AI Driven Stock Reports - newser.com
Volume spikes in Zynex Inc. stock – what they meanJuly 2025 EndofMonth & Fast Entry High Yield Stock Tips - newser.com
Zynex, Inc. (NASDAQ:ZYXI) Q3 2025 Earnings Call Transcript - Insider Monkey
Detecting support and resistance levels for Zynex Inc.Weekly Trade Review & Verified Short-Term Plans - newser.com
Zynex Stock Plummets -64% With 6-Day Losing Streak - Trefis
Zynex Inc (ZYXI) Q3 2025 Earnings Call Highlights: Navigating Financial Challenges Amid ... By GuruFocus - Investing.com Canada
Earnings call transcript: Zynex Q3 2025 results miss forecasts, stock tumbles - Investing.com Australia
Zynex Inc (ZYXI) Q3 2025 Earnings Call Highlights: Navigating Financial Challenges Amid ... - Yahoo Finance
Zynex, Inc. (ZYXI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Zynex Inc Stock (ZYXI) Financials Data
Revenue
Net Income
Cash Flow
EPS
Zynex Inc Stock (ZYXI) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| MOORHEAD DANIEL J | CHIEF FINANCIAL OFFICER |
Feb 03 '25 |
Sale |
7.68 |
10,000 |
76,800 |
19,738 |
0.77%
0.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):